Literature DB >> 446975

Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin.

H Isaka, H Yoshii, A Otsuji, M Koike, Y Nagai, M Koura, K Sugiyasu, T Kanabayashi.   

Abstract

Carcinogenicity of phenacetin was tested using Sprague-Dawley rats. Two groups of animals containing 50 males and 50 females per group were fed respectively with 2.5% and 1.25% phenacetin diet for 18 months and fed thereafter with basal diet for 6 months. Control animals containing 65 males and 65 females were fed with basal diet for 24 months. Animals surviving more than 24 months were regarded as effective animals and killed. Rats that died of tumor development within 24 months were also regarded effective animals. Every organ from the killed and dead animals was fixed in 10% formaldehyde solution and examined histopathologically. Effective number of rats was 27 males and 27 females in 2.5% phenacetin feeding group, and 22 males and 25 females in 1.25% phenacetin feeding group. In control group, 19 males and 25 females were effective. Neoplasms including spontaneous tumors were detected in 26 out of 27 males (96.3%) and 21 out of 27 females (77.8%) of 2.5% phenacetin feeding group, and in 20 out of 22 males (90.9%) and 19 out of 25 females (76.0%) of 1.25% phenacetin feeding group. In control group, 1 out of 19 males (5.3%) and 6 out of 25 females (24.0%) showed spontaneous tumor development. Histopathologically, carcinomas of the nasal cavity, such as adenocarcinoma, squamous cell carcinoma, and transitional cell carcinoma, and the urinary passage, as renal cell carcinoma of the kidney pelvis, and transitional cell carcinoma of the urinary bladder, were most conspicuous, suggesting the target organs of phenacetin carcinogenesis. Males showed higher tumor incidence compared to females. The higher the concentration of phenacetin given, higher incidence of tumors was observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446975

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  11 in total

Review 1.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  Animal experiments regarding a possible carcinogenic effect of phenacetin on the resting and proliferating urothelium stimulated by cyclophosphamide.

Authors:  E Kunze; H H Wöltjen; B Hartmann; W Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 3.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 4.  Respiratory tract lesions in noninhalation studies.

Authors:  Donald M Sells; Amy E Brix; Abraham Nyska; Micheal P Jokinen; Denise P Orzech; Nigel J Walker
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

Review 5.  Biotransformation enzymes in the rodent nasal mucosa: the value of a histochemical approach.

Authors:  M S Bogdanffy
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

Review 6.  Transgenic rat models for mutagenesis and carcinogenesis.

Authors:  Takehiko Nohmi; Kenichi Masumura; Naomi Toyoda-Hokaiwado
Journal:  Genes Environ       Date:  2017-02-01

Review 7.  Reactive metabolites of phenacetin and acetaminophen: a review.

Authors:  J A Hinson
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

8.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

Review 9.  Cell proliferation and nasal carcinogenesis.

Authors:  T M Monticello; E A Gross; K T Morgan
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

10.  Modification by analgesics of lesion development in the urinary tract and various other organs of rats pretreated with dihydroxy-di-N-propylnitrosamine and uracil.

Authors:  M A Shibata; M Sano; A Hagiwara; R Hasegawa; T Shirai
Journal:  Jpn J Cancer Res       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.